You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 5, NOVEMBER 1938 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

ENLARGEMENT OF THE LIVER IN DIABETIC CHILDREN

I. ITS INCIDENCE, ETIOLOGY AND NATURE

ALEXANDER MARBLE, M.D.; PRISCILLA WHITE, M.D.; ISABEL K. BOGAN, M.D.; RACHEL M. SMITH, A.B.

Arch Intern Med. 1938;62(5):740-750.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the past few years we have been impressed with the fact that in children with severe diabetes mellitus which has not been brought under satisfactory control, well marked enlargement of the liver may occur. In this paper we are reporting studies of 60 children (54 living and 6 dead) with pronounced hepatomegaly from among 1,077 patients (815 living and 262 dead) in whom the onset of diabetes occurred at the age of 15 years or under; the list as here presented is not complete. In view of the large number of cases we regard enlargement of the liver as one of the outstanding complications of uncontrolled severe juvenile diabetes. The cause of the increase in size, the nature of the enlargement—whether fatty, glycogenous or otherwise—and the specific treatment present difficult and interesting problems.

As Hanssen1 has pointed out, little mention of gross hepatomegaly in human diabetes is to . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the George F. Baker Clinic, Elliott P. Joslin, M.D., Medical Director, New England Deaconess Hospital.


Footnotes

This work was aided by a grant from the Chemical Foundation, Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1938 American Medical Association. All Rights Reserved.